# How Astragalin Modulates Glucose Uptake and Insulin Secretion in β-Cell Lines

**Authors:** Paola Miranda Sulis, Alice Lima Rosa Mendes, Paula Waiss Zanusso Bunick, Karina Cesca, Carine Royer, Bruna Antunes Zaniboni, Fernanda Carvalho Cavalari, Guilherme Brasil Pintarelli, André Luiz Andreotti Dagostin, Fátima Regina Mena Barreto Silva

PMC · DOI: 10.3390/ph19030508 · Pharmaceuticals · 2026-03-20

## TL;DR

Astragalin improves glucose uptake and insulin secretion in pancreatic β-cells by affecting potassium and calcium channels, suggesting it could help treat diabetes.

## Contribution

This study reveals astragalin's direct modulation of ionic mechanisms in β-cells to enhance insulin secretion.

## Key findings

- Astragalin increases glucose uptake in a time-dependent manner in β-cell lines.
- Insulin secretion is significantly enhanced after 1 hour of astragalin exposure.
- Astragalin reduces potassium currents and promotes calcium-dependent insulin exocytosis.

## Abstract

Background/Objectives: Type 2 diabetes mellitus (T2DM) is characterized by chronic hyperglycemia and insulin resistance, leading to progressive metabolic dysfunction. Flavonoids, such as astragalin, have reported antidiabetic potential; however, their direct effects on pancreatic β-cell ionic mechanisms and insulin secretion remain unclear. This study aimed to investigate the effects of astragalin on glucose uptake, insulin secretion, and membrane ionic currents in pancreatic β-cell lines. Methods: Murine MIN6 and rat INS-1 pancreatic β-cells were used as experimental models. Following astragalin treatment, glucose uptake was quantified by bioluminescence, and insulin secretion was measured by ELISA. Ionic currents were analyzed using the whole-cell patch-clamp technique. Selective pharmacological blockers targeting ATP-sensitive K+ channels (KATP), voltage-dependent K+ channels (Kv), and L-type voltage-dependent Ca2+ channels were applied to elucidate the underlying mechanisms. Results: Astragalin increased glucose uptake in a time-dependent manner, reaching a plateau between 3 and 5 h. Insulin secretion was significantly enhanced after 1 h of exposure to 100 µM astragalin. Patch-clamp recordings demonstrated that astragalin reduced potassium channel currents in pancreatic β-cells. Pharmacological modulation confirmed the involvement of KATP, Kv, and L-type Ca2+ channels. Verapamil attenuated the insulinotropic effect, supporting the role of calcium influx in astragalin-induced insulin exocytosis. Conclusions: Astragalin enhances glucose uptake and stimulates insulin secretion in pancreatic β-cells through modulation of potassium and calcium channels, promoting calcium-dependent exocytosis. These findings support its potential as a candidate for antidiabetic therapeutic strategies.

## Linked entities

- **Chemicals:** astragalin (PubChem CID 5282102), verapamil (PubChem CID 2520)
- **Diseases:** Type 2 diabetes mellitus (MONDO:0005148)
- **Species:** Mus musculus (taxon 10090), Rattus norvegicus (taxon 10116)

## Full-text entities

- **Diseases:** insulin resistance (MESH:D007333), T2DM (MESH:D003924), hyperglycemia (MESH:D006943), metabolic dysfunction (MESH:D008659)
- **Chemicals:** K+ (MESH:D011188), calcium (MESH:D002118), Ca2+ (-), Verapamil (MESH:D014700), Flavonoids (MESH:D005419), ATP (MESH:D000255), Glucose (MESH:D005947), Astragalin (MESH:C001579)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028945/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028945/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028945/full.md

---
Source: https://tomesphere.com/paper/PMC13028945